Ember Therapeutics
Thomas J. Schnitzer, M.D., Ph.D. , serves as the scientific advisor. He is a Professor in Physical Medicine and Rehabilitation and a Professor in Medicine-Rheumatology at the Northwestern University Feinberg School of Medicine. He has experience in clinical trial methodology. Prior to joining Northwestern University, Dr. Schnitzer was Professor and Director of rheumatology and geriatric medicine at Rush-Presbyterian-St. Luke’s Medical Center. He has also served as Co-Director of the Center of Research on Health and Aging at Rush-Presbyterian-St. Luke’s Medical Center in Chicago. Dr. Schnitzer is affiliated with the Multidisciplinary Clinical Research Center in Rheumatology. Dr. Schnitzer has written over one hundred journal articles, book chapters, and abstracts covering the field of osteoarthritis, osteoporosis, and pain management. He graduated summa cum laude with a Bachelor of Arts degree from Princeton University and cum laude with a medical degree from Harvard Medical School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Ember Therapeutics
Ember Therapeutics is a product-focused company translating its world-class biology in the emerging area of brown fat and recent breakthroughs in understanding the mechanisms of selective insulin sensitivity into a proprietary pipeline of peripherally-acting treatments for metabolic disease, including Type 2 diabetes and obesity.